Plus Therapeutics, Inc.
PSTV
$5.50
-$0.03-0.54%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -6.95M | -5.71M | -4.42M | 5.15M | -17.40M |
| Total Depreciation and Amortization | 109.00K | 145.00K | 77.00K | 77.00K | 181.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 1.02M | 670.00K | 539.00K | -6.52M | 12.49M |
| Change in Net Operating Assets | -419.00K | -1.36M | 1.26M | -4.50M | -1.44M |
| Cash from Operations | -6.24M | -6.26M | -2.55M | -5.80M | -6.17M |
| Capital Expenditure | -818.00K | -30.00K | -27.00K | -7.00K | -3.00K |
| Sale of Property, Plant, and Equipment | -- | 0.00 | 0.00 | 0.00 | 30.00K |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -7.72M | -1.05M | 1.32M | -4.63M | 3.53M |
| Cash from Investing | -8.53M | -1.08M | 1.30M | -4.63M | 3.56M |
| Total Debt Issued | 1.00M | 750.00K | 0.00 | 0.00 | 3.74M |
| Total Debt Repaid | -1.10M | 0.00 | 0.00 | 0.00 | -7.00M |
| Issuance of Common Stock | -- | 3.00M | 16.86M | 3.02M | 15.66M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 9.14M | -949.00K | -4.55M | -220.00K | -- |
| Cash from Financing | 9.04M | 2.80M | 12.31M | 2.80M | 12.41M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -5.74M | -4.53M | 11.06M | -7.63M | 9.79M |